Eli Lilly Financial Ratios
NYSE: LLYHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Eli Lilly ratio analysis
Eli Lilly earned a net margin of 31.7% in FY 2025, up from 23.5% a year earlier. Gross margin was 83.0% compared with a median of 77.7% over the prior 9 years. Return on equity reached 77.8%, meaning Eli Lilly generated 0.78 dollars of profit for every dollar of shareholders' equity, an unusually high figure that often reflects a small equity base after share buybacks.
Debt-to-equity stood at 1.60 versus 2.36 the year before, and the current ratio was 1.58. At the end of FY 2025, LLY traded at 47.1 times earnings; across the 9 fiscal years shown, its year-end P/E ranged from 14.8 to 100.5, with a median of 45.1. Valuation ratios use the closing share price on each fiscal year-end date and diluted shares from the income statement; profitability and leverage ratios use reported annual figures. Current valuation multiples are on the statistics page.
Summary generated from market data by MetaCap's automated system. Methodology
Eli Lilly financial ratios (annual)
| Ratio | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| P/E ratio (at fiscal year end) | 47.07 | 66.78 | 100.50 | 53.02 | 45.13 | 24.87 | 14.82 | 36.63 | — | 28.51 |
| Price / sales | 14.87 | 15.64 | 15.38 | 11.56 | 8.85 | 6.24 | 5.50 | 5.48 | 4.45 | 3.67 |
| Price / book | 36.53 | 49.34 | 48.71 | 30.98 | 27.90 | 27.16 | 47.06 | 11.99 | 7.66 | 5.56 |
| Gross margin | 83.0% | 81.3% | 79.2% | 76.8% | 74.2% | 77.7% | 78.8% | 78.2% | 77.7% | 73.1% |
| Net margin | 31.7% | 23.5% | 15.4% | 21.9% | 19.7% | 25.2% | 37.3% | 15.0% | -1.0% | 12.9% |
| Free cash flow margin | 13.8% | 8.3% | 2.3% | 20.1% | 21.4% | 20.8% | 17.0% | 20.1% | 22.7% | 18.0% |
| Return on equity (ROE) | 77.8% | 74.2% | 48.6% | 58.6% | 62.2% | 109.8% | 319.1% | 32.9% | -1.8% | 19.5% |
| Return on assets (ROA) | 18.4% | 13.5% | 8.2% | 12.6% | 11.4% | 13.3% | 21.2% | 7.4% | -0.5% | 7.1% |
| Debt / equity | 1.60 | 2.36 | 2.34 | 1.52 | 1.88 | 2.94 | 5.88 | 1.05 | 1.18 | 0.74 |
| Current ratio | 1.58 | 1.15 | 0.94 | 1.05 | 1.23 | 1.40 | 1.16 | 1.73 | 1.32 | 1.37 |
| Revenue growth | 44.7% | 32.0% | 19.6% | 0.8% | 15.4% | 9.9% | 3.8% | 7.6% | -5.9% | 6.3% |
| EPS growth | 96.0% | 101.9% | -15.9% | 12.7% | -9.9% | -23.6% | 184.0% | — | -107.4% | 14.2% |